Rheumatic Heart Disease Market, Global Outlook and Forecast 2022-2028

March 2022 | 116 pages | ID: R2487C583A64EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Rheumatic Heart Disease in Global, including the following market information:

Global Rheumatic Heart Disease Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Rheumatic Heart Disease market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Myocarditis Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Rheumatic Heart Disease include Abbott Laboratories, Bayer, BIOTRONIK, Boston Scientific, Bristol-Myers Squibb, C. R. Bard, Cardinal Health, Cook Medical and Roche, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rheumatic Heart Disease companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Rheumatic Heart Disease Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Rheumatic Heart Disease Market Segment Percentages, by Type, 2021 (%)

• Myocarditis
• Pericarditis

Global Rheumatic Heart Disease Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Rheumatic Heart Disease Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Diagnostic Centre
• Research Centre

Global Rheumatic Heart Disease Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Rheumatic Heart Disease Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Rheumatic Heart Disease revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Rheumatic Heart Disease revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott Laboratories
• Bayer
• BIOTRONIK
• Boston Scientific
• Bristol-Myers Squibb
• C. R. Bard
• Cardinal Health
• Cook Medical
• Roche
• GE Healthcare
• InterValve
• Novartis
• On-X Life Technologies
• Osypka Medical
• Otsuka
• PerkinElmer
• Pfizer
• Reckitt Benckiser
• Siemens Healthineers
• Toray

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Rheumatic Heart Disease Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Rheumatic Heart Disease Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL RHEUMATIC HEART DISEASE OVERALL MARKET SIZE

2.1 Global Rheumatic Heart Disease Market Size: 2021 VS 2028
2.2 Global Rheumatic Heart Disease Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Rheumatic Heart Disease Players in Global Market
3.2 Top Global Rheumatic Heart Disease Companies Ranked by Revenue
3.3 Global Rheumatic Heart Disease Revenue by Companies
3.4 Top 3 and Top 5 Rheumatic Heart Disease Companies in Global Market, by Revenue in 2021
3.5 Global Companies Rheumatic Heart Disease Product Type
3.6 Tier 1, Tier 2 and Tier 3 Rheumatic Heart Disease Players in Global Market
  3.6.1 List of Global Tier 1 Rheumatic Heart Disease Companies
  3.6.2 List of Global Tier 2 and Tier 3 Rheumatic Heart Disease Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Rheumatic Heart Disease Market Size Markets, 2021 & 2028
  4.1.2 Myocarditis
  4.1.3 Pericarditis
4.2 By Type - Global Rheumatic Heart Disease Revenue & Forecasts
  4.2.1 By Type - Global Rheumatic Heart Disease Revenue, 2017-2022
  4.2.2 By Type - Global Rheumatic Heart Disease Revenue, 2023-2028
  4.2.3 By Type - Global Rheumatic Heart Disease Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Rheumatic Heart Disease Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Diagnostic Centre
  5.1.4 Research Centre
5.2 By Application - Global Rheumatic Heart Disease Revenue & Forecasts
  5.2.1 By Application - Global Rheumatic Heart Disease Revenue, 2017-2022
  5.2.2 By Application - Global Rheumatic Heart Disease Revenue, 2023-2028
  5.2.3 By Application - Global Rheumatic Heart Disease Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Rheumatic Heart Disease Market Size, 2021 & 2028
6.2 By Region - Global Rheumatic Heart Disease Revenue & Forecasts
  6.2.1 By Region - Global Rheumatic Heart Disease Revenue, 2017-2022
  6.2.2 By Region - Global Rheumatic Heart Disease Revenue, 2023-2028
  6.2.3 By Region - Global Rheumatic Heart Disease Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Rheumatic Heart Disease Revenue, 2017-2028
  6.3.2 US Rheumatic Heart Disease Market Size, 2017-2028
  6.3.3 Canada Rheumatic Heart Disease Market Size, 2017-2028
  6.3.4 Mexico Rheumatic Heart Disease Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Rheumatic Heart Disease Revenue, 2017-2028
  6.4.2 Germany Rheumatic Heart Disease Market Size, 2017-2028
  6.4.3 France Rheumatic Heart Disease Market Size, 2017-2028
  6.4.4 U.K. Rheumatic Heart Disease Market Size, 2017-2028
  6.4.5 Italy Rheumatic Heart Disease Market Size, 2017-2028
  6.4.6 Russia Rheumatic Heart Disease Market Size, 2017-2028
  6.4.7 Nordic Countries Rheumatic Heart Disease Market Size, 2017-2028
  6.4.8 Benelux Rheumatic Heart Disease Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Rheumatic Heart Disease Revenue, 2017-2028
  6.5.2 China Rheumatic Heart Disease Market Size, 2017-2028
  6.5.3 Japan Rheumatic Heart Disease Market Size, 2017-2028
  6.5.4 South Korea Rheumatic Heart Disease Market Size, 2017-2028
  6.5.5 Southeast Asia Rheumatic Heart Disease Market Size, 2017-2028
  6.5.6 India Rheumatic Heart Disease Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Rheumatic Heart Disease Revenue, 2017-2028
  6.6.2 Brazil Rheumatic Heart Disease Market Size, 2017-2028
  6.6.3 Argentina Rheumatic Heart Disease Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Rheumatic Heart Disease Revenue, 2017-2028
  6.7.2 Turkey Rheumatic Heart Disease Market Size, 2017-2028
  6.7.3 Israel Rheumatic Heart Disease Market Size, 2017-2028
  6.7.4 Saudi Arabia Rheumatic Heart Disease Market Size, 2017-2028
  6.7.5 UAE Rheumatic Heart Disease Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott Laboratories
  7.1.1 Abbott Laboratories Corporate Summary
  7.1.2 Abbott Laboratories Business Overview
  7.1.3 Abbott Laboratories Rheumatic Heart Disease Major Product Offerings
  7.1.4 Abbott Laboratories Rheumatic Heart Disease Revenue in Global Market (2017-2022)
  7.1.5 Abbott Laboratories Key News
7.2 Bayer
  7.2.1 Bayer Corporate Summary
  7.2.2 Bayer Business Overview
  7.2.3 Bayer Rheumatic Heart Disease Major Product Offerings
  7.2.4 Bayer Rheumatic Heart Disease Revenue in Global Market (2017-2022)
  7.2.5 Bayer Key News
7.3 BIOTRONIK
  7.3.1 BIOTRONIK Corporate Summary
  7.3.2 BIOTRONIK Business Overview
  7.3.3 BIOTRONIK Rheumatic Heart Disease Major Product Offerings
  7.3.4 BIOTRONIK Rheumatic Heart Disease Revenue in Global Market (2017-2022)
  7.3.5 BIOTRONIK Key News
7.4 Boston Scientific
  7.4.1 Boston Scientific Corporate Summary
  7.4.2 Boston Scientific Business Overview
  7.4.3 Boston Scientific Rheumatic Heart Disease Major Product Offerings
  7.4.4 Boston Scientific Rheumatic Heart Disease Revenue in Global Market (2017-2022)
  7.4.5 Boston Scientific Key News
7.5 Bristol-Myers Squibb
  7.5.1 Bristol-Myers Squibb Corporate Summary
  7.5.2 Bristol-Myers Squibb Business Overview
  7.5.3 Bristol-Myers Squibb Rheumatic Heart Disease Major Product Offerings
  7.5.4 Bristol-Myers Squibb Rheumatic Heart Disease Revenue in Global Market (2017-2022)
  7.5.5 Bristol-Myers Squibb Key News
7.6 C. R. Bard
  7.6.1 C. R. Bard Corporate Summary
  7.6.2 C. R. Bard Business Overview
  7.6.3 C. R. Bard Rheumatic Heart Disease Major Product Offerings
  7.6.4 C. R. Bard Rheumatic Heart Disease Revenue in Global Market (2017-2022)
  7.6.5 C. R. Bard Key News
7.7 Cardinal Health
  7.7.1 Cardinal Health Corporate Summary
  7.7.2 Cardinal Health Business Overview
  7.7.3 Cardinal Health Rheumatic Heart Disease Major Product Offerings
  7.7.4 Cardinal Health Rheumatic Heart Disease Revenue in Global Market (2017-2022)
  7.7.5 Cardinal Health Key News
7.8 Cook Medical
  7.8.1 Cook Medical Corporate Summary
  7.8.2 Cook Medical Business Overview
  7.8.3 Cook Medical Rheumatic Heart Disease Major Product Offerings
  7.8.4 Cook Medical Rheumatic Heart Disease Revenue in Global Market (2017-2022)
  7.8.5 Cook Medical Key News
7.9 Roche
  7.9.1 Roche Corporate Summary
  7.9.2 Roche Business Overview
  7.9.3 Roche Rheumatic Heart Disease Major Product Offerings
  7.9.4 Roche Rheumatic Heart Disease Revenue in Global Market (2017-2022)
  7.9.5 Roche Key News
7.10 GE Healthcare
  7.10.1 GE Healthcare Corporate Summary
  7.10.2 GE Healthcare Business Overview
  7.10.3 GE Healthcare Rheumatic Heart Disease Major Product Offerings
  7.10.4 GE Healthcare Rheumatic Heart Disease Revenue in Global Market (2017-2022)
  7.10.5 GE Healthcare Key News
7.11 InterValve
  7.11.1 InterValve Corporate Summary
  7.11.2 InterValve Business Overview
  7.11.3 InterValve Rheumatic Heart Disease Major Product Offerings
  7.11.4 InterValve Rheumatic Heart Disease Revenue in Global Market (2017-2022)
  7.11.5 InterValve Key News
7.12 Novartis
  7.12.1 Novartis Corporate Summary
  7.12.2 Novartis Business Overview
  7.12.3 Novartis Rheumatic Heart Disease Major Product Offerings
  7.12.4 Novartis Rheumatic Heart Disease Revenue in Global Market (2017-2022)
  7.12.5 Novartis Key News
7.13 On-X Life Technologies
  7.13.1 On-X Life Technologies Corporate Summary
  7.13.2 On-X Life Technologies Business Overview
  7.13.3 On-X Life Technologies Rheumatic Heart Disease Major Product Offerings
  7.13.4 On-X Life Technologies Rheumatic Heart Disease Revenue in Global Market (2017-2022)
  7.13.5 On-X Life Technologies Key News
7.14 Osypka Medical
  7.14.1 Osypka Medical Corporate Summary
  7.14.2 Osypka Medical Business Overview
  7.14.3 Osypka Medical Rheumatic Heart Disease Major Product Offerings
  7.14.4 Osypka Medical Rheumatic Heart Disease Revenue in Global Market (2017-2022)
  7.14.5 Osypka Medical Key News
7.15 Otsuka
  7.15.1 Otsuka Corporate Summary
  7.15.2 Otsuka Business Overview
  7.15.3 Otsuka Rheumatic Heart Disease Major Product Offerings
  7.15.4 Otsuka Rheumatic Heart Disease Revenue in Global Market (2017-2022)
  7.15.5 Otsuka Key News
7.16 PerkinElmer
  7.16.1 PerkinElmer Corporate Summary
  7.16.2 PerkinElmer Business Overview
  7.16.3 PerkinElmer Rheumatic Heart Disease Major Product Offerings
  7.16.4 PerkinElmer Rheumatic Heart Disease Revenue in Global Market (2017-2022)
  7.16.5 PerkinElmer Key News
7.17 Pfizer
  7.17.1 Pfizer Corporate Summary
  7.17.2 Pfizer Business Overview
  7.17.3 Pfizer Rheumatic Heart Disease Major Product Offerings
  7.17.4 Pfizer Rheumatic Heart Disease Revenue in Global Market (2017-2022)
  7.17.5 Pfizer Key News
7.18 Reckitt Benckiser
  7.18.1 Reckitt Benckiser Corporate Summary
  7.18.2 Reckitt Benckiser Business Overview
  7.18.3 Reckitt Benckiser Rheumatic Heart Disease Major Product Offerings
  7.18.4 Reckitt Benckiser Rheumatic Heart Disease Revenue in Global Market (2017-2022)
  7.18.5 Reckitt Benckiser Key News
7.19 Siemens Healthineers
  7.19.1 Siemens Healthineers Corporate Summary
  7.19.2 Siemens Healthineers Business Overview
  7.19.3 Siemens Healthineers Rheumatic Heart Disease Major Product Offerings
  7.19.4 Siemens Healthineers Rheumatic Heart Disease Revenue in Global Market (2017-2022)
  7.19.5 Siemens Healthineers Key News
7.20 Toray
  7.20.1 Toray Corporate Summary
  7.20.2 Toray Business Overview
  7.20.3 Toray Rheumatic Heart Disease Major Product Offerings
  7.20.4 Toray Rheumatic Heart Disease Revenue in Global Market (2017-2022)
  7.20.5 Toray Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Rheumatic Heart Disease Market Opportunities & Trends in Global Market
Table 2. Rheumatic Heart Disease Market Drivers in Global Market
Table 3. Rheumatic Heart Disease Market Restraints in Global Market
Table 4. Key Players of Rheumatic Heart Disease in Global Market
Table 5. Top Rheumatic Heart Disease Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Rheumatic Heart Disease Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Rheumatic Heart Disease Revenue Share by Companies, 2017-2022
Table 8. Global Companies Rheumatic Heart Disease Product Type
Table 9. List of Global Tier 1 Rheumatic Heart Disease Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Rheumatic Heart Disease Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Rheumatic Heart Disease Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Rheumatic Heart Disease Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Rheumatic Heart Disease Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Rheumatic Heart Disease Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Rheumatic Heart Disease Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Rheumatic Heart Disease Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Rheumatic Heart Disease Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Rheumatic Heart Disease Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Rheumatic Heart Disease Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Rheumatic Heart Disease Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Rheumatic Heart Disease Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Rheumatic Heart Disease Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Rheumatic Heart Disease Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Rheumatic Heart Disease Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Rheumatic Heart Disease Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Rheumatic Heart Disease Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Rheumatic Heart Disease Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Rheumatic Heart Disease Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Rheumatic Heart Disease Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Rheumatic Heart Disease Product Offerings
Table 32. Abbott Laboratories Rheumatic Heart Disease Revenue (US$, Mn), (2017-2022)
Table 33. Bayer Corporate Summary
Table 34. Bayer Rheumatic Heart Disease Product Offerings
Table 35. Bayer Rheumatic Heart Disease Revenue (US$, Mn), (2017-2022)
Table 36. BIOTRONIK Corporate Summary
Table 37. BIOTRONIK Rheumatic Heart Disease Product Offerings
Table 38. BIOTRONIK Rheumatic Heart Disease Revenue (US$, Mn), (2017-2022)
Table 39. Boston Scientific Corporate Summary
Table 40. Boston Scientific Rheumatic Heart Disease Product Offerings
Table 41. Boston Scientific Rheumatic Heart Disease Revenue (US$, Mn), (2017-2022)
Table 42. Bristol-Myers Squibb Corporate Summary
Table 43. Bristol-Myers Squibb Rheumatic Heart Disease Product Offerings
Table 44. Bristol-Myers Squibb Rheumatic Heart Disease Revenue (US$, Mn), (2017-2022)
Table 45. C. R. Bard Corporate Summary
Table 46. C. R. Bard Rheumatic Heart Disease Product Offerings
Table 47. C. R. Bard Rheumatic Heart Disease Revenue (US$, Mn), (2017-2022)
Table 48. Cardinal Health Corporate Summary
Table 49. Cardinal Health Rheumatic Heart Disease Product Offerings
Table 50. Cardinal Health Rheumatic Heart Disease Revenue (US$, Mn), (2017-2022)
Table 51. Cook Medical Corporate Summary
Table 52. Cook Medical Rheumatic Heart Disease Product Offerings
Table 53. Cook Medical Rheumatic Heart Disease Revenue (US$, Mn), (2017-2022)
Table 54. Roche Corporate Summary
Table 55. Roche Rheumatic Heart Disease Product Offerings
Table 56. Roche Rheumatic Heart Disease Revenue (US$, Mn), (2017-2022)
Table 57. GE Healthcare Corporate Summary
Table 58. GE Healthcare Rheumatic Heart Disease Product Offerings
Table 59. GE Healthcare Rheumatic Heart Disease Revenue (US$, Mn), (2017-2022)
Table 60. InterValve Corporate Summary
Table 61. InterValve Rheumatic Heart Disease Product Offerings
Table 62. InterValve Rheumatic Heart Disease Revenue (US$, Mn), (2017-2022)
Table 63. Novartis Corporate Summary
Table 64. Novartis Rheumatic Heart Disease Product Offerings
Table 65. Novartis Rheumatic Heart Disease Revenue (US$, Mn), (2017-2022)
Table 66. On-X Life Technologies Corporate Summary
Table 67. On-X Life Technologies Rheumatic Heart Disease Product Offerings
Table 68. On-X Life Technologies Rheumatic Heart Disease Revenue (US$, Mn), (2017-2022)
Table 69. Osypka Medical Corporate Summary
Table 70. Osypka Medical Rheumatic Heart Disease Product Offerings
Table 71. Osypka Medical Rheumatic Heart Disease Revenue (US$, Mn), (2017-2022)
Table 72. Otsuka Corporate Summary
Table 73. Otsuka Rheumatic Heart Disease Product Offerings
Table 74. Otsuka Rheumatic Heart Disease Revenue (US$, Mn), (2017-2022)
Table 75. PerkinElmer Corporate Summary
Table 76. PerkinElmer Rheumatic Heart Disease Product Offerings
Table 77. PerkinElmer Rheumatic Heart Disease Revenue (US$, Mn), (2017-2022)
Table 78. Pfizer Corporate Summary
Table 79. Pfizer Rheumatic Heart Disease Product Offerings
Table 80. Pfizer Rheumatic Heart Disease Revenue (US$, Mn), (2017-2022)
Table 81. Reckitt Benckiser Corporate Summary
Table 82. Reckitt Benckiser Rheumatic Heart Disease Product Offerings
Table 83. Reckitt Benckiser Rheumatic Heart Disease Revenue (US$, Mn), (2017-2022)
Table 84. Siemens Healthineers Corporate Summary
Table 85. Siemens Healthineers Rheumatic Heart Disease Product Offerings
Table 86. Siemens Healthineers Rheumatic Heart Disease Revenue (US$, Mn), (2017-2022)
Table 87. Toray Corporate Summary
Table 88. Toray Rheumatic Heart Disease Product Offerings
Table 89. Toray Rheumatic Heart Disease Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Rheumatic Heart Disease Segment by Type in 2021
Figure 2. Rheumatic Heart Disease Segment by Application in 2021
Figure 3. Global Rheumatic Heart Disease Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Rheumatic Heart Disease Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Rheumatic Heart Disease Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Rheumatic Heart Disease Revenue in 2021
Figure 8. By Type - Global Rheumatic Heart Disease Revenue Market Share, 2017-2028
Figure 9. By Application - Global Rheumatic Heart Disease Revenue Market Share, 2017-2028
Figure 10. By Region - Global Rheumatic Heart Disease Revenue Market Share, 2017-2028
Figure 11. By Country - North America Rheumatic Heart Disease Revenue Market Share, 2017-2028
Figure 12. US Rheumatic Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Rheumatic Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Rheumatic Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Rheumatic Heart Disease Revenue Market Share, 2017-2028
Figure 16. Germany Rheumatic Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 17. France Rheumatic Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Rheumatic Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Rheumatic Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Rheumatic Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Rheumatic Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Rheumatic Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Rheumatic Heart Disease Revenue Market Share, 2017-2028
Figure 24. China Rheumatic Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Rheumatic Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Rheumatic Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Rheumatic Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 28. India Rheumatic Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Rheumatic Heart Disease Revenue Market Share, 2017-2028
Figure 30. Brazil Rheumatic Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Rheumatic Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Rheumatic Heart Disease Revenue Market Share, 2017-2028
Figure 33. Turkey Rheumatic Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Rheumatic Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Rheumatic Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Rheumatic Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Laboratories Rheumatic Heart Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bayer Rheumatic Heart Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. BIOTRONIK Rheumatic Heart Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Boston Scientific Rheumatic Heart Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bristol-Myers Squibb Rheumatic Heart Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. C. R. Bard Rheumatic Heart Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Cardinal Health Rheumatic Heart Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Cook Medical Rheumatic Heart Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Roche Rheumatic Heart Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. GE Healthcare Rheumatic Heart Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. InterValve Rheumatic Heart Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Novartis Rheumatic Heart Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. On-X Life Technologies Rheumatic Heart Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Osypka Medical Rheumatic Heart Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Otsuka Rheumatic Heart Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. PerkinElmer Rheumatic Heart Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Pfizer Rheumatic Heart Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Reckitt Benckiser Rheumatic Heart Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Siemens Healthineers Rheumatic Heart Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Toray Rheumatic Heart Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)